Companies
- Companies
- Company details
Aphios
Aphios is developing enabling nanotechnologies and enhanced therapeutics for health maintenance and the treatment of human diseases (cancer, infectious diseases including HIV-AIDS and CNS disorders)The company in detail
Summary
Aphios was founded in 1993. The company was formed as a result of a forward merger with Bio-Eng, a Massachusetts. Aphios' product pipeline includes small pharmaceutically active molecules from medicinal plants and marine organisms, and large protein macromolecules that are crucial to the functioning of the human genome.
R&D
To view this information, you must subscribe to Pharmalicensing Intelligence.
Partnerships
To view this information, you must subscribe to Pharmalicensing Intelligence.
Deals
To view this information, you must subscribe to Pharmalicensing Intelligence.
Senior management
To view this information, you must subscribe to Pharmalicensing Intelligence.
Board of directors
To view this information, you must subscribe to Pharmalicensing Intelligence.
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Nov 2010 - 197 pages - $600
Jul 2010 - 53 pages - $750
Nov 2010 - 38 pages - $600
Feb 2011 - 209 pages - $3,500
May 2011 - 36 pages - $500
Mar 2011 - 42 pages - $500
Jan 2010 - 221 pages - $3,835
AIDS-related Kaposi’s Sarcoma (ARKS) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
Jun 2011 - 60 pages - $2,000
Apr 2011 - 167 pages - $500
Contact details
To view this information, you must subscribe to Pharmalicensing Intelligence.
Head office
Related companies
Related categories
- Industry sector
- Biotechnology / Human therapeutics
- Drug delivery / Oral solid
- Drug delivery / Parenteral
- Drug delivery / Systemic
- Drug delivery / Topical
- Drug delivery / Pulmonary
- Drug discovery
- Medical device / Therapeutic medical equipment
- Pharmaceutical / Prescription
- Pharmaceutical / OTC/Non-Prescription
- Pharmaceutical / Generics
- Pharmaceutical / Personal Care
- Therapeutic target
- Blood and forming organs
- Central Nervous System / CNS (other)
- Dermatological
- Immune related disorders
- Infectious diseases
- Oncology
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us